NASHVILLE, Tenn.--(BUSINESS WIRE)--Aegis Sciences Corporation, one of the nation’s leading laboratory sciences companies, announced today the acquisition of Diagnovus LLC, a molecular diagnostics laboratory providing individualized genetic information, which fundamentally changes the way physicians treat patients.
“The asset acquisition of Diagnovus allows Aegis to expand our healthcare laboratory testing services,” stated Aegis Founder, Chairman, and CEO Dr. David L. Black. “The delivery of patient-specific genetic information to physicians will improve management of disease and prescribing of necessary medication.”
Help employers find you! Check out all the jobs and post your resume.
